Axalta Coating Systems (AXTA) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Aug, 2026Executive summary
Achieved record net sales of $1.35 billion in Q2 2026, up 3% year-over-year, with Adjusted EBITDA of $305 million and Adjusted Diluted EPS of $0.72, up 13% year-over-year.
Free cash flow reached $107 million, up 6% year-over-year, and total net leverage dropped to 2.2x, the lowest in company history.
Net income was $89 million for Q2 2026, down year-over-year due to $31 million in merger-related costs.
The proposed all-stock merger with AkzoNobel is pending, with shareholder votes scheduled for August 2026 and expected closing in late 2026 or early 2027.
On track to achieve key milestones in the 2026 A Plan, with $600 million in expected annual cost synergies from the merger.
Financial highlights
Adjusted net income rose 10% year-over-year to $153 million, excluding $31 million in merger-related costs.
Adjusted EBITDA margin reached 22.7%, up 30 basis points year-over-year, marking the tenth consecutive quarter above 20%.
Operating cash flow improved to $152 million, and gross debt was reduced by $135 million in the first half of 2026.
Interest expense decreased 16% year-over-year.
Net income for the six months ended June 30, 2026 was $179 million, down from $208 million in the prior year period.
Outlook and guidance
Q3 2026 net sales expected to grow low single digits year-over-year; Adjusted EBITDA guidance of $295–$305 million.
Full-year 2026 Adjusted Diluted EPS guidance is $2.55–$2.70; free cash flow expected to exceed $500 million.
Expects to exit the year with net leverage below 2x.
Capital expenditures for FY 2026 projected at $180–$200 million.
Latest events from Axalta Coating Systems
- Shareholders to vote on transformative Axalta merger as financials remain stable amid divestments.AXTA
Proxy filing - Shareholders to vote on a transformative $25B all-stock merger creating a global coatings leader.AXTA
Proxy filing - Q1 2026 beat guidance with strong cash flow, Mobility growth, and AkzoNobel merger progress.AXTA
Q1 2026 - Record 2025 results, robust governance, and a pending AkzoNobel merger highlight this proxy.AXTA
Proxy filing - Director elections, auditor appointment, and executive pay are up for shareholder vote.AXTA
Proxy filing - Record 2025 margins and EBITDA; major merger and strong 2026 outlook with synergy potential.AXTA
Q4 2025 - Record Q3 sales and margin expansion led to raised 2024 guidance and strong growth outlook.AXTA
Q3 2024 - Record Q2 sales, margin gains, and raised 2024 guidance driven by robust segment growth.AXTA
Q2 2024 - Record 2024 results, margin expansion, and strong 2025 outlook despite macro risks.AXTA
Q4 2024